ANNE J CRENESSE-COZIEN
Allopathic & Osteopathic Physicians|Family Medicine BROOKLYN, NY NPI 1306807144
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine NY GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$1,030.93
- Category: General Payments
- Program years: PY2018–2024
- Record count: 47
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $186.21 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $186.21 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $103.04 | 4 |
| ABBVIE INC. | $48.74 | 3 |
| Novo Nordisk AS | $34.43 | 2 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096752450 | Novo Nordisk Inc | $19.58 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096955413 | Novo Nordisk Inc | $14.85 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103514448 | ABBVIE INC. | $18.27 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103514450 | ABBVIE INC. | $16.53 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103514452 | ABBVIE INC. | $13.94 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116247742 | GlaxoSmithKline, LLC. | $24.86 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116373388 | GlaxoSmithKline, LLC. | $24.87 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116506238 | GlaxoSmithKline, LLC. | $24.86 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116721911 | GlaxoSmithKline, LLC. | $28.45 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.